India's own first drug - from Biocon.
...iotechnology firm, launched its second novel 'lab-to-market' molecule, Alzumab, to treat chronic plaque psor...t a cost 50 per cent lower than the existing one. Biocon is bringing Alzumab (a biologic) in the form of a...3919 days ago
Comment on "India's own first drug - from Biocon."
Alzumab is the "the world’s first anti-CD6 antibody drug" for treating psoriasis.3917 days ago